TD Asset Management
AXSM icon

TD Asset Management’s Axsome Therapeutics AXSM Stock Holding History

TD Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.92M Sell
24,204
-2,928
-11% -$635K 0.01% 776
2026
Q1 		$4.59M Sell
27,132
-14,840
-35% -$2.56M ﹤0.01% 812
2025
Q4 		$7.67M Sell
41,972
-2,220
-5% -$310K 0.01% 725
2025
Q3 		$5.37M Buy
44,192
+22,914
+108% +$2.58M ﹤0.01% 776
2025
Q2 		$2.22M Buy
21,278
+12,294
+137% +$1.3M ﹤0.01% 906
2025
Q1 		$1.05M Buy
+8,984
New +$1.02M ﹤0.01% 1067
2024
Q1 		– Sell
-16,000
Closed -$1.27M – 1389
2023
Q4 		$1.27M Buy
+16,000
New +$1.07M ﹤0.01% 1125
2021
Q3 		– Sell
-35,116
Closed -$1.71M – 1528
2021
Q2 		$1.71M Buy
35,116
+8,800
+33% +$528K ﹤0.01% 1138
2021
Q1 		$1.49M Sell
26,316
-2,500
-9% -$176K ﹤0.01% 1173
2020
Q4 		$2.35M Buy
28,816
+3,200
+12% +$239K ﹤0.01% 996
2020
Q3 		$1.82M Hold
25,616
– – ﹤0.01% 934
2020
Q2 		$2.11M Buy
25,616
+8,600
+51% +$662K ﹤0.01% 867
2020
Q1 		$1M Sell
17,016
-22,400
-57% -$1.83M ﹤0.01% 996
2019
Q4 		$4.07M Buy
39,416
+3,216
+9% +$130K 0.01% 763
2019
Q3 		$733K Buy
36,200
+9,700
+37% +$249K ﹤0.01% 1113
2019
Q2 		$682K Buy
+26,500
New +$531K ﹤0.01% 1125

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

TD Asset Management's AXSM Position: Q2 2026 in Review

TD Asset Management reduced its Axsome Therapeutics (AXSM) stake by 11% in Q2 2026, selling an estimated $635K and leaving 24,204 shares worth $5.92M. The position accounts for 0.01% of the portfolio, ranked #776.

TD Asset Management first reported a position in AXSM in Q2 2019 and has held it in 16 quarters since. The position peaked at $7.67M in Q4 2025. 504 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • TD Asset Management held 24,204 shares of Axsome Therapeutics worth $5.92M as of Q2 2026.
  • TD Asset Management sold 2,928 Axsome Therapeutics shares in Q2 2026, an estimated $635K.
  • Axsome Therapeutics made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #776 holding.
  • TD Asset Management first reported a position in Axsome Therapeutics in Q2 2019 and has held it in 16 quarters since.
  • TD Asset Management's Axsome Therapeutics position peaked at $7.67M in Q4 2025.
  • 504 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.